ORAL PEPTIDES
BPC-157 (Oral)
Body-protection compound, oral capsule format. 60 count, 500 mcg per capsule.
Bundle & save
Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility
Free shipping
on orders over $150
Damage protection
replacement guarantee
Secure checkout
256-bit SSL
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
99.3%
purity
✓ Passed full QC panel
- Variant
- BPC-157 (Oral) · 60 caps · 500 mcg
- Lot #
- AML-2026-0532
- Labeled
- 60 caps · 500 mcg
- Tested
- 2026-04-30
Full QC panel
- Purity (HPLC)
- 99.3%
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Structure
- CAS Number
- 137525-51-0
- Molecular Formula
- C62H98N16O22
- Molecular Weight
- 1419.5 g/mol
- Sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Type
- Research peptide
- PubChem
- CID 9941957 ↗
Biological targets
Interactions
- Primary target
- No single canonical receptor; activity linked to the VEGFR2–eNOS axis
- Pathway
- VEGFR2 / nitric-oxide; FAK–paxillin; EGR-1 / NAB2
- Mechanism
- Cytoprotective pentadecapeptide; modulates angiogenesis, the nitric-oxide system, and growth-factor signaling
- Research area
- Soft-tissue and tendon repair, gut protection, angiogenesis
Physical properties
Handling & Storage
- Appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in sterile or bacteriostatic water; reconstitute prior to use
- Storage
- Room temp, dry, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
NEURAL REGENERATION RESEARCH
Pentadecapeptide BPC 157 and the central nervous system
2022 · PMID 34380875
Vukojevic J et al.
View Source ↗PHARMACEUTICALS (BASEL, SWITZERLAND)
Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review
2025 · PMID 40005999
Józwiak M et al.
View Source ↗PHARMACEUTICALS (BASEL, SWITZERLAND)
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity
2024 · PMID 38675421
Sikiric P et al.
View Source ↗HSS JOURNAL : THE MUSCULOSKELETAL JOURNAL OF HOSPITAL FOR SPECIAL SURGERY
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
2025 · PMID 40756949
Vasireddi N et al.
View Source ↗BIOMEDICINES
Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle
2022 · PMID 36551977
Staresinic M et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Research updates from Aminologix
Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.